Bacteriophage therapy of a Vibrio parahaemolyticus infection caused by a multiple-antibiotic-resistant O3:K6 pandemic clinical strain

Journal of Infectious Diseases

Volumn 210, Issue 1, 2014, Pages 72-78

  Jun, Jin Woo ^a   Shin, Tae Hoon ^a   Kim, Ji Hyung ^b   Shin, Sang Phil ^a   Han, Jee Eun ^a   Heo, Gang Joon ^c   De Zoysa, Mahanama ^d   Shin, Gee Wook ^e   Chai, Ji Young ^f   Park, Se Chang ^a  

^a Seoul National University   (South Korea)

^b Korea Research Institute of Ships and Ocean Engineering   (South Korea)

^c Chungbuk National University   (South Korea)

^d Chungnam National University   (South Korea)

^e Chonbuk National University   (South Korea)

^f Bundang Jesaeng Hospital   (South Korea)

Author keywords

Bacteriophage; Pandemic strains; PVp 1; Vibrio parahaemolyticus

Indexed keywords

ANTIBIOTIC AGENT; PROTEIN VP1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIOPHAGE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; IN VIVO STUDY; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; SINGLE DRUG DOSE; VIBRIO PARAHAEMOLYTICUS; VIBRIO PARAHAEMOLYTICUS INFECTION; VIBRIO VULNIFICUS;

ANIMALS; BACTERIOPHAGES; BIOLOGICAL THERAPY; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VIBRIO INFECTIONS; VIBRIO PARAHAEMOLYTICUS;

EID: 84904349129     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu059     Document Type: Article

References (28)

1. Daniels NA, MacKinnon L, Bishop R, et al. Vibrio parahaemolyticus infections in the United States, 1973-1998. J Infect Dis 2000; 181:1661-6.
2. Matsumoto C, Okuda J, Ishibashi M, et al. Pandemic spread of an O3: K6 clone of Vibrio parahaemolyticus and emergence of related strains evidenced by arbitrarily primed PCR and toxRS sequence analyses. J Clin Microbiol 2000; 38:578-85.
3. Okoh AI, Igbinosa EO. Antibiotic susceptibility profiles of some Vibrio strains isolated fromwastewater final effluents in a rural community of the Eastern Cape Province of South Africa. BMC Microbiol 2010; 10:143.
4. Jun JW, Kim JH, Choresca CH, et al. Isolation, molecular characterization, and antibiotic susceptibility of Vibrio parahaemolyticus in Korean seafood. Foodborne Pathog Dis 2012; 9:224-31.
5. Biswas B, Adhya S,Washart P, et al. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect Immun 2002; 70:204-10.
6. Bruttin A, Bru′ssow H. Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob Agents Chemother 2005; 49:2874-8.
7. Chhibber S, Kaur S, Kumari S. Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice. J Med Microbiol 2008; 57:1508-13.
8. Kumari S, Harjai K, Chhibber S. Efficacy of bacteriophage treatment in murine burn wound infection induced by Klebsiella pneumoniae. J Microbiol Biotechnol 2009; 19:622-8.
9. Sulakvelidze A, Kutter E. Bacteriophage therapy in humans. In: Kutter ESulakvelidze A, eds. Bacteriophages: biology and applications. Boca Raton, FL: CRC Press, 2005:381-436.
10. Vinodkumar CS, Neelagund YF, Kalsurmath S. Bacteriophage in the treatment of experimental septicemic mice from a clinical isolate of multidrug resistant Klebsiella pneumoniae. J Commun Dis 2005; 37:18-29.
11. Gutiérrez D, Martínez B, Rodríguez A, García P. Isolation and characterization of bacteriophages infecting Staphylococcus epidermidis. Curr Microbiol 2010; 61:601-8.
12. Kim JH, Jun JW, Choresca CH, Shin SP, Han JE, Park SC. Complete genome sequence of a novel marine siphovirus, pVp-1, infecting Vibrio parahaemolyticus. J Virol 2012; 86:7013-4.
13. Verma V, Harjai K, Chhibber S. Characterization of a T7-like lytic bacteriophage of Klebsiella pneumoniae B5055: a potential therapeutic agent. Curr Microbiol 2009; 59:274-81.
14. Sunagar R, Patil SA, Chandrakanth RK. Bacteriophage therapy for Staphylococcus aureus bacteremia in streptozotocin-induced diabetic mice. Res Microbiol 2010; 161:854-60.
15. Harlow E, Lane D. Using antibodies, a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1999.
16. Wichels A, Biel SS, Gelderblom HR, Brinkhoff T, Muyzer G, Schu′tt C. Bacteriophage diversity in the North Sea. Appl Environ Microbiol 1998; 64: 4128-33.
17. Clarke T. Drug companies snub antibiotics as pipeline threatens to run dry. Nature 2003; 425:225.
18. Norrby SR, Nord CE, Finch R, European Society of Clinical Microbiology and Infectious Diseases. Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect Dis 2005; 5:115-9.
19. Wenzel RP. The antibiotic pipeline-challenges, costs, and values. N Engl J Med 2004; 351:523-6.
20. Summers WC. Bacteriophage therapy. Annu Rev Microbiol 2001; 55:437-51.
21. Cerveny KE, DePaola A, Duckworth DH, Gulig PA. Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextrantreated mice. Infect Immun 2002; 70:6251-62.
22. Merril CR, Biswas B, Carlton R, et al. Long-circulating bacteriophage as antibacterial agents. Proc Natl Acad Sci U S A 1996; 93:3188-92.
23. Smith HW, Huggins MB. Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. J Gen Microbiol 1982; 128:307-18.
24. Housby JN, Mann NH. Phage therapy. Drug Discov Today 2009; 14:536-40.
25. Boratynski J, Syper D, Weberdabrowska B, Lusiak-Szelachowska M, Pozniak G, Gorski A. Preparation of endotoxin-free bacteriophages. Cell Mol Biol Lett 2004; 9:253-9.
26. Merabishvili M, Pirnay JP, Verbeken G, et al. Quality-controlled smallscale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLoS One 2009; 4:e4944.
27. Skurnik M, Strauch E. Phage therapy: facts and fiction. Int J Med Microbiol 2006; 296:5-14.
28. Skurnik M, Pajunen M, Kiljunen S. Biotechnological challenges of phage therapy. Biotechnol Lett 2007; 29:995-1003.